The moderate decrease in invasive cervical cancer incidence rates in Spain (1980-2004): Limited success of opportunistic screening?

Annals of Oncology

Volumn 21, Issue SUPPL.3, 2010, Pages

  Perez Gomez B ^a,g   Martinez C ^b,g   Navarro, C ^c,g   Franch, P ^d   Galceran, J ^e   Marcos Gragera, R ^f   Martinez, R ^h   Sanchez S ⁱ   Hernandez R ⁱ   Natal, C ⁱ   Martos, C ^j   Aragones N ^a   Ezponda, C ^k   Ramirez C ^l   Diaz Garcia J M ^l   Fernandez D ^m   Perucha, J ⁿ  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^c Health Authority   (Spain)

^d Mallorca Cancer Registry   (Spain)

^e INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^f DEPARTMENT OF HEALTH   (Spain)

^g CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^h Basque Country Regional Authority   (Spain)

ⁱ Health and Medical Services Authority   (Spain)

^j INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^k INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^l Health and Social Welfare Authority   (Spain)

^m Canary Islands Cancer Registry   (Spain)

ⁿ La Rioja Cancer Registry   (Spain)

more..

Author keywords

Adenocarcinoma; Age; Cervical cancer; Incidence; Spain; Squamous cell carcinoma

Indexed keywords

ADENOCARCINOMA; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER INVASION; CANCER LOCALIZATION; CANCER PREVENTION; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CHILD; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; INFANT; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; RISK ASSESSMENT; RISK REDUCTION; SCHOOL CHILD; SPAIN; SQUAMOUS CELL CARCINOMA; TREND STUDY; UTERINE CERVIX CARCINOMA;

EID: 84859129442     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq093     Document Type: Article

References (40)

1. IARC. Cervical Cancer Screening. IARC Handbooks of Cancer Prevention. Lyon, France: IARC 2005.
2. Parkin DM, Whelan SL, Ferlay J, Suarez B. Cancer Incidence in Five Continents. 2005, Vol. I-VIII. IARC CancerBase No. 7. Lyon, France: IARC.
3. Bray F, Loos AH, McCarron P et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 2005; 14: 677-686.
4. International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: Collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 2007; 120: 885-891.
5. International Collaboration of Epidemiological Studies of Cervical Cancer. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006; 118: 1481-1495.
6. Bulk S, Berkhof J, Bulkmans NW et al. Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands. Br J Cancer 2006; 94: 171-175.
7. Ferlay J, Autier P, Boniol M et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-592.
8. Bosch FX, Lorincz A, Munoz N et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-265.
9. Parkin DM, Ferlay J, Shanmugaratnam L et al. Chapter 4: Histological groups. In Curado M, Edwards B, Shin HR et al. (eds): Cancer Incidence in Five Continents. Vol. IX. (IARC Scientific Publications No. 160). Lyon, France: IARC 2007; 45-55.
10. McCullagh P, Nelder J. Generalized Linear Models. London, UK: Chapman & Hall, 1989.
11. Pollan M, Pastor-Barriuso R, Ardanaz E et al. Recent decline in breast cancer incidence in Spain linked to screening saturation. J Natl Cancer Inst 2009; 101: 1584-1591.
12. Osmond C, Gardner MJ. Age, period and cohort models applied to cancer mortality rates. Stat Med 1982; 1: 245-259.
13. Holford TR. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health 1991; 12: 425-457.
14. Arbyn M, Raifu A, Autier P, Ferlay J. Burden of cervical cancer in Europe: estimates for 2004. Ann Oncol 2007; 18: 1708-1715.
15. De Vuyst H, Clifford G, Li N, Franceschi S. HPV infection in Europe. Eur J Cancer 2009; 45: 2632-2639.
16. Bray F, Carstensen B, Moller H et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev 2005; 14: 2191-2199.
17. Instituto Nacional de Estadística. Encuesta de Salud y Hábitos Sexuales. http://www.ine.es/prodyser/pubweb/saludyhs03/saludyhs03.htm (accessed 15 October 2009).
18. Moscicki AB, Schiffman M, Kjaer S, Villa LL. Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine 2006; 24 (Suppl 3): S342-S351.
19. Riphagen FE, Lehert P. A survey of contraception in five west European countries. J Biosoc Sci 1989; 21: 23-46.
20. Vaccarella S, Franceschi S, Herrero R et al. Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiol Biomarkers Prev 2006; 15: 326-333.
21. Bosch FX, Castellsague X, Munoz N et al. Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst 1996; 88: 1060-1067.
22. Castellsague X, Bosch FX, Munoz N. The male role in cervical cancer. Salud Publica Mex 2003; 45 (Suppl 3): S345-S353.
23. Moreno V, Bosch FX, Munoz N et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 2002; 359: 1085-1092.
24. Vaccarella S, Herrero R, Dai M et al. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev 2006; 15: 2148-2153.
25. Muñoz F. [Reproduction and marriage in Spain (1970-1990)]. Rev Int Sociol 1995; 199-237.
26. Sistema de Información Microbiológica. http://www.isciii.es/jsps/centros/epidemiologia/informacionMicrobiologic a.jsp (accessed 15 October 2009).
27. Castellsague X, Bosch FX, Munoz N. Environmental co-factors in HPV carcinogenesis. Virus Res 2002; 89: 191-199.
28. Ministerio de Sanidad y Política Social, Secretaría del Plan Nacional del SIDA, y Centro Nacional de Epidemiología. Vigilancia del SIDA en España. Actualización a 31 de diciembre de 2008. Informe Semestral, N 2. http://www.isciii.es/htdocs/centros/epidemiologia/epi_sida.jsp (accessed 15 October 2009).
29. Rodriguez-Rieiro C, Aragones N, Pollan M et al. [Temporal trends of cervical cancer mortality rates among regions in Spain: 1975-2004]. Med Clin (Barc) 2009; 133: 41-46.
30. Galceran J, Marcos-Gragera R, Izquierdo A, Borras J. Carcinoma invasor y lesiones premalignas del cuello uterino en los registros poblacionales: utilidad y limitaciones. In De SanjoséS, García A (eds): Virus del Papiloma humano y cáncer: Epidemiología y prevención. 4a monografía de la Sociedad Española de Epidemiología. Sociedad Española de Epidemiología. Barcelona, Spain: Emisa 2006; 15-27.
31. Sala M, Castells X, Queiroz G, Salas D. Situación del cribado de cáncer de cérvix en España. In Castells X, Sala M, Ascunce N et al. (eds): Descripción del cribado del cáncer en España. Proyecto DESCRIC. Madrid: Plan de Calidad para el Sistema Nacional de SaludMinisterio de Sanidad y Consumo. Agència d'Avaluacióde Tecnologia i Recerca Mèdiques de Cataluña; Informes de Evaluación de Tecnologías Sanitarias, AATRM núm. 2006/01. 2007.
32. Ministerio de Sanidad y Política Social. Encuesta Nacional de Salud de España [Spanish National Health Survey]. http://pestadistico.msc.es/PEMSC25/. Ministerio de Sanidad y Política Social (accessed 15 October 2009).
33. Belza MJ, Koerting A, Suárez M. Informe fipse: Jóvenes, relaciones sexuales y riesgo de infección por VIH. Encuesta de Salud y Hábitos Sexuales. España 2003. Fundación para la investigación y la prevención del SIDA en España, 2006.
34. de Sanjose S, Alejo M, Combalia N et al. [Screening history in women with infiltrating uterine cancer]. Gac Sanit 2006; 20: 166-167.
35. Andrae B, Kemetli L, Sparen P et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 2008; 100: 622-629.
36. Reimers LL, Anderson WF, Rosenberg PS et al. Etiologic heterogeneity for cervical carcinoma by histopathologic type, using comparative age-periodcohort models. Cancer Epidemiol Biomarkers Prev 2009; 18: 792-800.
37. Safaeian M, Schiffman M, Gage J et al. Detection of precancerous cervical lesions is differential by human papillomavirus type. Cancer Res 2009; 69: 3262-3266.
38. Lacey JV Jr., Swanson CA, Brinton LA et al. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer 2003; 98: 814-821.
39. Maruthur NM, Bolen SD, Brancati FL, Clark JM. The association of obesity and cervical cancer screening: a systematic review and meta-analysis. Obesity (Silver Spring) 2009; 17: 375-381.
40. Gunnell AS, Tran TN, Torrang A et al. Synergy between cigarette smoking and human papillomavirus type 16 in cervical cancer in situ development. Cancer Epidemiol Biomarkers Prev 2006; 15: 2141-2147.